Second only to skin cancer, prostate cancer is the most common type of cancer in American men—with about one in six receiving that diagnosis during his lifetime. More than 217,000 men in the United States are diagnosed with prostate cancer each year, while more than two million American men with the diagnosis remain alive today.
Team-based treatment at UCHealth
At UCHealth locations in metro Denver, Fort Collins, and Colorado Springs, a caring team of doctors and support professionals from many fields work together to develop the best plan of care for you, and they stay with you from your initial appointment through treatment and aftercare.
You receive doctor-managed care that emphasizes wellness and healing for you as a whole person—our complementary and integrative medicine specialists incorporate options such as massage therapy, acupuncture, and exercise consultation into your treatment. Your expert medical team members may include:
- Medical oncologists
- Radiation oncologists
- Clinical research coordinators (CRCs)
- Nurse practitioners (NPs)
- Nurses or Registered Nurses (RNs)
- Oncology social workers
- Integrative medicine and complementary care therapists
Precision treatment with da Vinci® robotic-assisted surgery
When you choose UCHealth, you gain access to surgeons skilled in the precision technology of robotic-assisted surgery with the da Vinci® Si system.
This advanced technology enables our highly experienced physicians to perform minimally invasive procedures for prostate cancer using smaller incisions, more detailed images inside the body, and precise control of the instruments. In many cases this means you recover faster and your hospital stay is shorter.
Immunotherapy treatment with Provenge®
Additional advanced treatment options at UCHealth for prostate cancer include Provenge®, a therapy that trains the body’s immune system to attack prostate cancer cells. The treatment involves removing your white blood cells, mixing these cells with a drug designed to target cancer cells, and infusing you with the treated blood.
Provenge is an FDA-approved therapy for men who have advanced prostate cancer that isn’t responding to hormonal therapies. Our University of Colorado Cancer Center participated in the original clinical trial for Provenge, so you can trust our extensive experience to deliver the best care for your specific situation.
Your medical team may also recommend participation in a clinical trial. UCHealth conducts hundreds of these “trials” of new treatments or drugs. Participation in a clinical trial may provide those who qualify with access to drugs and vaccines years before they are widely available.